CA116-003

Name: CA116-003
Availability: InStock
Author: Medable Inc.

Medable Inc.

Everyone

Downloads

Everyone

Learn more

About this app

You are invited to participate in the Bristol Myers Squibb CA116-003 study. This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms.

Application for participants in Bristol Myers Squibb CA116-003 study.

Updated on

May 20, 2024

Data safety

Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.

No data shared with third parties
Learn more about how developers declare sharing
No data collected
Learn more about how developers declare collection
Data is encrypted in transit
You can request that data be deleted